lisocabtagene maraleucel

Bristol-Myers' CAR-T gets priority review, mid-August PDUFA date
Fierce Biotech
Thu, 02/13/20 - 11:04 am
Bristol-Myers Squibb
FDA
lisocabtagene maraleucel
priority review
CAR-T